Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127076882 | 12707688 | 2 | F | 20160830 | 20160901 | 20160905 | PER | US-PFIZER INC-2016412210 | PFIZER | 55.00 | YR | F | Y | 89.81000 | KG | 20160905 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127076882 | 12707688 | 1 | PS | CLINDAMYCIN HCL | CLINDAMYCIN HYDROCHLORIDE | 1 | Oral | 150 MG, 3X/DAY | 50162 | 150 | MG | CAPSULE, HARD | TID | ||||||
| 127076882 | 12707688 | 2 | SS | CLINDAMYCIN HCL | CLINDAMYCIN HYDROCHLORIDE | 1 | Oral | 300 MG, 4X/DAY | 50162 | 300 | MG | CAPSULE, HARD | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127076882 | 12707688 | 1 | Infection |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127076882 | 12707688 | Disease progression | |
| 127076882 | 12707688 | Drug ineffective | |
| 127076882 | 12707688 | Facial pain | |
| 127076882 | 12707688 | Nodule | |
| 127076882 | 12707688 | Swelling face |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127076882 | 12707688 | 1 | 20160825 | 0 |